These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 8567128

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J, de Oliveira AC, Vergara MP, Montanheiro P, Bonasser F, Meilman Ferreira C, Smid J, Duarte AJ.
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Tropical spastic paraparesis/HTLV-I associated myelopathy. Etiology and clinical spectrum.
    Rodgers-Johnson PE.
    Mol Neurobiol; 1994 Mar; 8(2-3):175-9. PubMed ID: 7999314
    [Abstract] [Full Text] [Related]

  • 25. HTLV-I-associated myelopathy following allogeneic bone marrow transplantation.
    Emmanouilides CE, Territo M.
    Bone Marrow Transplant; 1999 Jul; 24(2):205-6. PubMed ID: 10455351
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil.
    Nobre V, Guedes AC, Martins ML, Barbosa-Stancioli EF, Serufo JC, Proietti FA, Ribas JG, Ferreira CE, Lambertucci JR, GIPH Interdisciplinary Group on HTLV-1/2 Research.
    Clin Infect Dis; 2006 Nov 15; 43(10):1257-63. PubMed ID: 17051489
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y, Sato T.
    Nihon Rinsho; 2013 May 15; 71(5):870-5. PubMed ID: 23777097
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.
    Lenzi ME, Cuzzi-Maya T, Oliveira AL, Andrada-Serpa MJ, Araújo AQ.
    Clin Infect Dis; 2003 Feb 15; 36(4):507-13. PubMed ID: 12567310
    [Abstract] [Full Text] [Related]

  • 33. Subtyping of human T cell lymphotropic virus type I from tropical spastic paraparesis/HTLV-associated myelopathy patients in Mozambique.
    Engelbrecht S, Koulinska I, Smith TL, Robson BA, Barreto J, van Rensburg EJ.
    AIDS Res Hum Retroviruses; 1999 Jan 01; 15(1):71-2. PubMed ID: 10024055
    [No Abstract] [Full Text] [Related]

  • 34. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
    Rafatpanah H, Pravica V, Faridhosseini R, Tabatabaei A, Ollier W, Poulton K, Thomson W, Hutchinson I.
    Iran J Immunol; 2007 Jun 01; 4(2):94-100. PubMed ID: 17652849
    [Abstract] [Full Text] [Related]

  • 35. HTLV-1 associated myelopathy/tropical spastic paraparesis: how far have we come?
    Morgan O.
    West Indian Med J; 2011 Oct 01; 60(5):505-12. PubMed ID: 22519224
    [No Abstract] [Full Text] [Related]

  • 36. Indigenous tropical spastic paraparesis in Madrid (Spain). Experience on screening of human T-lymphotropic virus.
    Ponce-Alonso M, Del Corral-Corral I, Ortiz-Rivera M, Anciones-Martín C, Mateos-Lindemann ML.
    Enferm Infecc Microbiol Clin; 2017 Oct 01; 35(7):441-443. PubMed ID: 26282070
    [Abstract] [Full Text] [Related]

  • 37. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
    Saito M, Usuku K, Nobuhara Y, Matsumoto W, Kodama D, Sabouri AH, Izumo S, Arimura K, Osame M.
    J Neurol Sci; 2004 Apr 15; 219(1-2):157-61. PubMed ID: 15050452
    [Abstract] [Full Text] [Related]

  • 38. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
    Lehky TJ, Levin MC, Kubota R, Bamford RN, Flerlage AN, Soldan SS, Leist TP, Xavier A, White JD, Brown M, Fleisher TA, Top LE, Light S, McFarland HF, Waldmann TA, Jacobson S.
    Ann Neurol; 1998 Dec 15; 44(6):942-7. PubMed ID: 9851439
    [Abstract] [Full Text] [Related]

  • 39. Comparison between various biosensor methods for human T-lymphotropic virus-1 (HTLV-1) detection.
    Kamali P, Zandi M, Ghasemzadeh-Moghaddam H, Fani M.
    Mol Biol Rep; 2022 Feb 15; 49(2):1513-1517. PubMed ID: 34797491
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
    Talledo M, López G, Huyghe JR, Verdonck K, Adaui V, González E, Best I, Clark D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L.
    J Med Virol; 2010 Mar 15; 82(3):460-6. PubMed ID: 20087941
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.